GLP1R and inflammatory bowel disease: For example, antidiabetic drugs may be poorly tolerated by non-diabetic patients due to potential adverse effects like hypoglycemia, GLP1-RA may not be appropriate for individuals suffering from inflammatory bowel diseases, and statins may not be appropriate for those with well-controlled cholesterol levels.